Download Files:
LM22A-4
SKU
HY-100673-10 mg
Category Reference compound
Tags Neurological Disease, Neuronal Signaling;Protein Tyrosine Kinase/RTK, Trk Receptor
$50 – $580
Products Details
Product Description
– LM22A-4 is a specific agonist of tyrosine kinase receptor B, used for neurological disease research.
Web ID
– HY-100673
Storage Temperature
– -20°C, 3 years; 4°C, 2 years (Powder)
Shipping
– Room Temperature
Applications
– Neuroscience-Neuromodulation
Molecular Formula
– C15H21N3O6
References
– [1]Kajiya M, et al. BDNF mimetic compound LM22A-4 regulates cementoblast differentiation via the TrkB-ERK/Akt signaling cascade. Int Immunopharmacol. 2014 Apr;19(2):245-52|[2]Yu G, et al. Protective effects of LM22A-4 on injured spinal cord nerves. Int J Clin Exp Pathol. 2015 Jun 1;8(6):6526-32. eCollection 2015.
CAS Number
– 37988-18-4
Molecular Weight
– 339.34
Compound Purity
– 98.53
SMILES
– O=C(C1=CC(C(NCCO)=O)=CC(C(NCCO)=O)=C1)NCCO
Clinical Information
– No Development Reported
Research Area
– Neurological Disease
Solubility
– DMSO : ≥ 29 mg/mL|H2O : ≥ 50 mg/mL
Target
– Trk Receptor
Pathway
– Neuronal Signaling;Protein Tyrosine Kinase/RTK
Product type
– Reference compound
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.